Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Effect of Raised CBF During CEA on Cognition in DM Patients



Principal Investigator
Eric J Heyer, M.D., Ph.D.

PI Address
Columbia University Medical Center
Department of Anesthesiology
New York, New York, United States, 10032

Contact Address
1st Contact: Anna Granat, BA
Phone: 212-305-8949 Email: a.granat@columbia.edu
2nd Contact: Eric Heyer, M.D., Ph.D. Phone: 212-305-9072 Email: ejh3@columbia.edu

Contact Email
a.granat@columbia.edu

Sponsor



Study Size Planned:400
Centers Planned:1
Min Age:18
Follow-up Duration:6 Months
ISRCTN#NCT00597545
Status:
This study is currently recruiting participants.

Purpose:
To determine if patients with adult-onset diabetes mellitus having the surgical procedure called carotid endarterectomy benefit from increasing blood flow to the brain with a "shunt".

Interventions:
Shunt
The use of a silicon tube, or shunt, as a temporary bypass can reduce the length of time that blood flow to the brain is interrupted during the operation

Location(s):
New York

Year Started: 2007

Design:
Interventional, Prevention, Randomized, Double Blind (Subject, Investigator), Uncontrolled, Single Group Assignment, Efficacy Study.

Inclusion Criteria
Ability to speak English; no history of permanent neurological impairment, Axis I psychiatric diagnosis or drug abuse; scheduled for elective carotid endarterectomy for treatment of carotid artery stenosis; diagnosed with diabetes mellitus or HbA1c value greater than 10%.

Exclusion Criteria
Younger than 18 yrs.

Patient Involvement:
First, all patients will be evaluated using a battery of neuropsychometric tests before and after surgery. Second, peripheral serum samples will be drawn before induction, before crossclamping the carotid artery, 15 minutes after crossclamping the carotid artery and 24 hours after surgery. They will be evaluated on the day of surgery. They will be evaluated 1 day, and 1 and 6 months after surgery.
We will randomly assign patients to either receive a "shunt" prophylactically if the surgeon determines that it is technically safe, even if conventional management does not indicate it is necessary, or a "shunt" only if it is indicated by EEG, "conventional" management. Subjects in the prophylactic group will receive a shunt even when by standard criteria they would not need to receive one.

Primary Outcome:
Increase or decrease in cognitive function.

Comments:
Scientific Name: Effect of Augmentation of Cerebral Blood Flow on Neuropsychometric Performance After Carotid Endarterectomy in Type II Diabetic Patients

Source of Information:
ClinicalTrials.gov

Web Links and Publications:
Effect of Raised CBF During CEA on Cognition in DM Patients
ClinicalTrials.gov

This information last updated on: 10/16/2009

Reviewed on: 09/14/2009.

UID: 1032

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009